Vitamins and type 2 diabetes mellitus

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 15, Issue 1, 2015, Pages 54-63

  Valdés Ramos, Roxana ^a   Laura, Guadarrama López Ana ^a   Elina, Martínez Carrillo Beatriz ^a   Donají, Benítez Arciniega Alejandra ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

Antioxidants; Type 2 diabetes mellitus; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ASCORBIC ACID; BIOTIN; CALBINDIN 1; COBALAMIN; COLECALCIFEROL; FOLIC ACID; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MENAQUINONE; NICOTINIC ACID; PHYTOMENADIONE; PROTEIN KINASE C; PYRIDOXINE; RETINOL; RETINOL BINDING PROTEIN 4; THIAMINE; TOCOPHEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VITAMIN; VITAMIN D; ANTIOXIDANT; CYANOCOBALAMIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; RISK FACTOR; VITAMIN SUPPLEMENTATION; ANIMAL; DIET THERAPY; DIETARY SUPPLEMENT; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FOLIC ACID; HUMANS; OXIDATIVE STRESS; VITAMIN B 12; VITAMINS;

EID: 84930913162     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530314666141111103217     Document Type: Article

References (153)

1. Zatalia, S.R. and Sanusi, H. (2013) The role of antioxidants in the pathophysiology, complications and management of diabetes mellitus. Acta. Med. Indones., 45(2), 141-147.
2. Brun, P.J.; Yang, K.J.; Lee, S.A.; Yuen, J.J. and Blaner, W.S. (2013) Retinoids: Potent regulators of metabolism. Biofactors, 39(2), 151-163.
3. Raghow, R. (2012) Metabolic balancing acts of vitamin A in type-2 diabetes and obesity. World J. Diabetes, 3(10), 174-177.
4. Polidori, M.C.; Mecocci, P.; Stahl, W.; Parente, B.; Cecchetti, R.; Cherubini, A.; Cao, P.; Sies, H. and Senin, U. (2000) Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab. Res. Rev., 16(1), 15-19.
5. Abahusain, M.A.; Wright, J.; Dickerson, J.W. and de Vol, E.B. (1999) Retinol, alpha-tocopherol and carotenoids in diabetes. Eur. J. Clin. Nutr., 53(8), 630-635.
6. Reunanen, A.; Knekt, P.; Aaran, R.K. and Aromaa, A. (1998) Serum antioxidants and risk of non-insulin dependent diabetes mellitus. Eur J Clin Nutr, 52(2), 89-93.
7. Gavrilov, V.; Harman-Boehm, I.; Amichay, D.; Tessler, G.; Shuster, T.; Friger, M. and Gorodischer, R. (2012) Kidney function and retinol status in type 2 diabetes mellitus patients. Acta Diabetol., 49(2), 137-143.
8. Kotnik, P.; Fischer-Posovsky, P. and Wabitsch, M. (2011) RBP4: a controversial adipokine. Eur. J. Endocrinol., 165, 703-711.
9. Pullakhandam, R.; Palika, R.; Ghosh, S. and Reddy, G.B. (2012) Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin. UBMB Life, 64(12), 975- 982.
10. Wolf, G. (2007) Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr. Rev., 65(5), 251-256.
11. Akbay, E.; Muslu, N.; Nayir, E.; Ozhan, O. and Kiykim, A. (2010) Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes. J Endocrinol Invest, 33(10), 725-729.
12. Wu, H.; Jia, W.; Bao, Y.; Lu, J.; Zhu, J.; Wang, R.; Chen, Y. and Xiang, K. (2008) Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract., 79(2), 185-190.
13. van Hoek, M.; Dehghan, A.; Zillikens, M.C.; Hofman, A.; Witteman, J.C. and Sijbrands, E.J. (2008) An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia, 51(8), 1423-1428.
14. Erikstrup, C.; Mortensen, O.H.; Nielsen, A.R.; Fischer, C.P.; Plomgaard, P.; Petersen, A.M.; Krogh-Madsen, R.; Lindegaard, B.; Erhardt, J.G.; Ullum, H.; Benn, C.S. and Pedersen, B.K. (2009) RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes. Metab., 11(3), 204-212.
15. Sasaki, H.; Iwasaki, T.; Kato, S. and Tada, N. (1995) High retinol/retinol-binding protein ratio in noninsulin-dependent diabetes mellitus. Am. J. Med. Sci., 310(5), 177-82.
16. Manolescu, D.C.; Sima, A. and Bhat, P.V. (2009) All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J. Nutr., 140(2), 311- 316.
17. Manzetti, S.; Zhang, J. and van der Spoel D. (2014) Thiamin function, metabolism, uptake and transport. Biochemistry, 53(5), 821-835.
18. Polizzi, F.C.; Andican, G.; Cetin, E.; Civelek, S.; Yumuk, V. and Burcak, G. (2012) Increased DNA-glycation in type 2 diabetic patients: the effect of thiamine and pyridoxine therapy. Exp Clin Endocrinol Diabetes, 120(6), 329-334.
19. Al-Attas, O.S.; Al-Daghri, N.M.; Alfadda, A.A.; Abd-Alrahman, S.H. and Sabico, S. (2012) Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. J. Endocrinol. Invest., 35(11), 951-956.
20. Waheed, P.; Naveed, A.K. and Ahmed, T. (2013) Thiamine deficiency and its correlation with dyslipiaemia in diabetics with microalbuminuria. J. Pak. Med. Assoc., 63(3), 340-345.
21. Gonzalez-Ortiz, M.; Martinez-Abundis, E.; Robles-Cervantes, J.A.; Ramirez-Ramirez, V. and Ramos-Zavala, M.G. (2010) Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naive patients with type 2 diabetes. Eur. J. Nutr., 50(2), 145-149.
22. Rabbani, N.; Alam, S.S.; Riaz, S.; Larkin, J.R.; Akhtar, M.W.; Shafi, T. and Thornalley, P.J. (2009) High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia, 52(2), 208-212.
23. 6: A Molecule for Human Health? Molecules, 15, 442-459.
24. Ahn, H.J.; Min, K.W. and Cho, Y.O. (2011) Assessment of vitamin B(6) status in Korean patients with newly diagnosed type 2 diabetes. Nutr. Res. Pract., 5(1), 34-39.
25. Song, Y., Cook, N.R., Albert, C.M., Van Denburgh, M. and Manson, J.E. (2009) Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes, 58(8), 1921-1928.
26. Unoki-Kubota, H.; Yamagishi, S.; Takeuchi, M.; Bujo, H. and Saito, Y. (2010) Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. Protein Pept. Lett., 17(9), 1177-1181.
27. Smolek, M.K.; Notaroberto, N.F.; Jaramillo, A.G. and Pradillo, L.R. (2013) Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol, 7, 1451-1458.
28. Maiese, K.; Zhong-Chong, Z.; Hou, J. and Chen-ShengY. (2009) The Vitamin Nicotinamide: Translating Nutrition into Clinical Care. Molecules, 14(9), 3446-3485.
29. Julius, U. and Fischer, S. (2013) Nicotinic acid as a lipid-modifying drug - a review. Atheroscler. Suppl., 14(1), 7-13.
30. Song, W.L. and FitzGerald, G.A. (2013) Niacin, an old drug with a new twist. J. Lipid. Res., 54(10), 2586-2594
31. Tavintharan, S.; Woon, K.; Pek, L.T.; Jauhar, N.; Dong, X.; Lim, S.C. and Sum, C.F. (2011) Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus. Atherosclerosis, 215(1), 176-179.
32. Sazonov, V.; Maccubbin, D.; Sisk, C.M. and Canner, P.L. (2013) Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int. J. Clin. Pract., 67(4), 297-302.
33. Zhou, S.S.; Li, D.; Sun, W.P.; Guo, M.; Lun, Y.Z.; Zhou, Y.M.; Xiao, F.C.; Jing, L.X.; Sun, S.X.; Zhang, L.B.; Luo, N.; Bian, F.N.; Zou, W.; Dong, L.B.; Zhao, Z.G.; Li, S.F.; Gong, X.J.; Yu, Z.G.; Sun, C.B.; Zheng, C.L.; Jiang, D.J. and Li, Z.N. (2009) Nicotinamide overload may play a role in the development of type 2 diabetes. World J. Gastroenterol., 15(45), 5674-5684.
34. Tong, L. (2013) Structure and function of biotin-dependent carboxylases. Cell Mol. Life Sci., 70(5), 863-891.
35. Sahin, K.; Tuzcu, M.; Orhan, C.; Sahin, N.; Kucuk, O.; Ozercan, I.H.; Juturu, V. and Komorowski, J.R. (2013) Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br. J. Nutr., 110(2), 197-205.
36. Sasaki, Y.; Sone, H.; Kamiyama, S.; Shimizu, M.; Shirakawa, H.; Kagawa, Y.; Komai, M. and Furukawa, Y. (2012) Administration of biotin prevents the development of insulin resistance in the skeletal muscles of Otsuka Long-Evans Tokushima Fatty rats. Food Funct., 3(4), 414-419.
37. 12 in Health and Disease. Nutrients, 2, 299-316.
38. Movva, S.; Alluri, R.V.; Venkatasubramanian, S.; Vedicherla, B.; Vattam, K.K.; Ahuja, Y.R. and Hasan, Q. (2011) Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications. Genet. Test Mol. Biomarker, 15(4), 257-261.
39. Rafnsson, S.B.; Saravanan, P.; Bhopal, R.S. and Yajnik, C.S. (2011) Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. Eur J Nutr, 50(2), 97-106.
40. Al-Maskari, M.Y.; Waly, M.I.; Ali, A.; Al-Shuaibi, Y.S. and Ouhtit, A. (2012) Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition, 28(7-8), e23-e26.
41. Ben Ahmed, H.; Bouzid, K.; Hassine, M.; Saadi, O.; Bahlous, A.; Abdelmoula, J.; Baccar, H; and Ben Mami. Ben Miled, F. (2014) Prevalence of non-conventional cardiovascular risk factors in Tunisian diabetics. Presse. Med., 43(1), e9-e16
42. Molina, M.; González, R.; Folgado, J., Real, J.T., Martinez-Hervas, S., Priego, A., Lorente, R., Chaves, F.J. and Ascaso, J.F. (2013) Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus [Article in Spanish]. Med. Clin. (Barc), 141(9), 382-386.
43. Li, J.; Shi, M.; Zhang, H.; Yan, L.; Xie, M.; Zhuang, L.; Zhu, Y. and Chen, J. (2012) Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clin. Nephrol., 77(4), 305-10.
44. Jianbo, L.; Yuche, C.; Ming, S.; Jingrong, T.; Qing, D.; Yu, Z.; Jiawei, C. and Hongxing, W. (2011) Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Res. Clin. Pract., 93(1), 38-42.
45. Ukinc, K.; Ersoz, H.O.; Karahan, C.; Erem, C.; Eminagaoglu, S.; Hacihasanoglu, A.B.; Yilmaz, M. and Kocak, M. (2009) Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine, 36(2), 255-261.
46. Satyanarayana, A.; Balakrishna, N.; Pitla, S.; Reddy, P.Y.; Mudili, S.; Lopamudra, P.; Suryanarayana, P.; Viswanath, K.; Ayyagari, R. and Reddy, G.B. (2011) Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One, 6(11), e26747.
47. Ebesunun, M.O. and Obajobi, E.O. (2012) Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan. Afr. Med. J., 12, 48.
48. Shargorodsky, M.; Boaz, M.; Pasternak, S.; Hanah, R.; Matas, Z.; Fux, A.; Beigel, Y. And Mashavi, M. (2009) Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Diabetes Metab. Res. Rev., 25(1), 70-75.
49. Kumthekar, A.A.; Gidwani, H.V. and Kumthekar, AB. (2012) Metformin associated B12 deficiency. J. Assoc. Physicians India, 60, 58-60.
50. Wile, D.J. and Toth, C. (2010) Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care, 33(1), 156-61.
51. de Groot-Kamphuis, D.M.; van Dijk, P.R.; Groenier, K.H.; Houweling, S.T.; Bilo, H.J. and Kleefstra, N. (2013) Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Neth. J. Med., 71(7), 386-390.
52. Sato, Y.; Ouchi, K.; Funase, Y.; Yamauchi, K. and Aizawa, T. (2013) Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr. J., 60(12), 1275-1280.
53. Sumitani, S.; Morita, S.; Utsu, Y.; Mukai, K.; Miki, S.; Sato, B.; Nakamura, H. and Kasayama, S. (2012) Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes: a prospective observational study. J. Med. Invest., 59(1-2), 166-173.
54. Nervo, M.; Lubini, A.; Raimundo, F.V.; Faulhaber, G.A.; Leite, C.; Fischer, L.M. and Furlanetto, T.W. (2011) Vitamin B12 in metformin-treated diabetic patients: a cross-sectional study in Brazil. Rev. Assoc. Med. Bras., 57(1), 46-49.
55. Calvo Romero, J.M. and Ramiro Lozano, J.M. (2012) Vitamin B(12) in type 2 diabetic patients treated with metformin. Endocrinol Nutr, 59(8), 487-490.
56. 12 levels in patients with type 2 diabetes mellitus. Endocr. Pract., 18(2), 179-184.
57. Leung, S.; Mattman, A.; Snyder, F.; Kassam, R.; Meneilly, G. and Nexo, E. (2010) Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients. Clin. Biochem., 43(9), 759-760.
58. Jawa, AA.; Akram, J.; Sultan, M.; Humayoun, M.A. and Raza, R. (2010) Nutrition-related vitamin B12 deficiency in patients in Pakistan with type 2 diabetes1 mellitus not taking metformin. Endocr Pract, 16(2), 205-208.
59. Moore, E.M.; Mander, A.G.; Ames, D.; Kotowicz, M.A.; Carne, R.P.; Brodaty, H.; Woodward, M.; Boundy, K.; Ellis, K.A.; Bush, A.I.; Faux, N.G.; Martins, R.; Szoeke, C.; Rowe, C. and Watters, D.A; AIBL Investigators. (2012) Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care, 36(10), 2981-2987.
60. Obeid, R.; Jung, J.; Falk, J.; Herrmann, W.; Geisel, J.; Friesenhahn- Ochs, B.; Lammert, F.; Fassbender, K. and Kostopoulos, P. (2013) Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie, 95(5), 1056-1061.
61. Aghamohammadi, V.; Gargari, B.P. and Aliasgharzadeh, A. (2011) Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J. Am. Coll. Nutr., 30(3), 210-215.
62. Jacobs, A.M. and Cheng, D. (2011) Management of diabetic smallfiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev. Neurol. Dis., 8(1-2), 39-47.
63. Farvid, M.S.; Homayouni, F.; Amiri, Z. and Adelmanesh, F. (2011) Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res. Clin. Pract., 93(1), 86-94.
64. Walker, M.J. Jr., Morris, L.M. and Cheng, D. (2010) Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'- phosphate. Rev. Neurol. Dis., 7(4), 132-139.
65. de Jager, J.; Kooy, A.; Lehert, P.; Wulffele, M.G.; van der Kolk, J.; Bets, D.; Verburg, J.; Donker, A.J. and Stehouwer, C.D. (2010) Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ, 340, c2181.
66. Pierce, S.A.; Chung, A.H. and Black, K.K. (2012) Evaluation of vitamin B12 monitoring in a veteran population on long-term, highdose metformin therapy. Ann. Pharmacother., 46(11), 1470-6.
67. 12 supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care, 35(2), 327-333.
68. Xu, Q.; Pan, J.; Yu, J.; Liu, X.; Liu, L.; Zuo, X.; Wu, P.; Deng, H.; Zhang, J. and Ji. A. (2013) Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Res. Clin. Pract., 101(2), 99-105.
69. Crider, K.S.; Yang, T.P.; Berry, R.J. and Bailey, L.B. (2012) Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role. Adv. Nutr., 3, 21-38.
70. Lazalde-Ramos, B.P.; Zamora-Perez, A.L.; Sosa-Macias, M.; Guerrero-Velazquez, C. and Zuniga-Gonzalez, G.M. (2012) DNA and oxidative damages decrease after ingestion of folic acid in patients with type 2 diabetes. Arch. Med. Res., 43(6), 476-781.
71. Gargari, B.P.; Aghamohammadi, V. and Aliasgharzadeh, A. (2011) Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res. Clin. Pract., 94(1), 33-38.
72. Aghamohammadi, V.; Gargari, B.P. and Aliasgharzadeh, A. (2011) Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J. Am. Coll. Nutr., 30(3), 210-215.
73. Mandl, J.; Szarka, A.; Bangheyl, G. (2009) Vitamin C: update on physiology and pharmacology. B. J. Pharmacol., 157, 1097-1110.
74. Odum, E.P.; Ejilemele, A.A. and Wakwe, V.C. (2012) Antioxidant status of type 2 diabetic patients in Port Harcourt, Nigeria. Niger. J. Clin. Pract., 15(1), 55-58.
75. Sundaram, R.K.; Bhaskar, A.; Vijayalingam, S.; Viswanathan, M.; Mohan, R. and Shanmugasundaram, K.R. (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Sci. (Lond), 90(4), 255-260.
76. Carter, P.; Gray, L.J.; Talbot, D.; Morris, D.H.; Khunti, K. and Davies, M.J. (2013) Fruit and vegetable intake and the association with glucose parameters: a cross-sectional analysis of the Let's Prevent Diabetes Study. Eur. J. Clin. Nutr., 67(1), 12-17.
77. Mazloom, Z.; Hejazi, N.; Dabbaghmanesh, M.H.; Tabatabaei, H.R.; Ahmadi, A. and Ansar, H. (2011) Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients. Pak. J. Biol. Sci., 14(19), 900-904.
78. Gokhale, N.H.; Acharya, A.B.; Patil, V.S.; Trivedi, D.J. and Thakur, S.L. (2013) A short-term evaluation of the relationship between plasma ascorbic acid levels and periodontal disease in systemically healthy and type 2 diabetes mellitus subjects. J. Diet. Suppl., 10(2), 93-104.
79. Mazloom, Z.; Ekramzadeh, M. and Hejazi, N. (2013) Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebocontrolled trial. Pak. J. Biol. Sci., 16(22), 1597-1600.
80. Rafighi, Z.; Shiva A.; Arab, S. and Mohd Yousof, R. (2013) Association of dietary vitamin C and E intake and antioxidant enzymes in type 2 diabetes mellitus patients. Glob. J. Health Sci., 5(3), 183-187.
81. Vujosevic, S.; Radojevic N.; Aligrudic S. and Bozovic D. (2014) Relationship between 25-Hydroxyvitamin D and Newly Diagnosed Type 2 Diabetes Mellitus in Postmenopausal Women with Osteoporosis. Med. Princ. Pract., 23, 229-233.
82. Hu, F.B.; Manson, J.E.; Stampfer, M.J.; Colditz, G.; Liu, S.; Solomon, C.G. and Willett, W.C. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med., 345(11), 790-797.
83. Lindstrom, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemio, K.; Hamalainen, H.; Harkonen, P.; Keinanen- Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Mannelin, M.; Paturi, M.; Sundvall, J.; Valle, T.T.; Uusitupa, M.; Tuomilehto, J. and Finnish Diabetes Preventiont Study Group. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle Arnson, Y., Amital, H. and Shoenfeld, Y. (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis., 66(9), 1137-1142.
84. Vujosevic S. Borozan intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet, 368(9548), 1673-1679.
85. Pittas, A.G.; Lau, J.; Hu, F.B. and Dawson-Hughes, B. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab., 92(6), 2017- 2029.
86. Mitri, J. and Pittas, AG. (2014) Vitamin D and diabetes. Endocrinol. Metab. Clin. North. Am., 43(1), 205-32
87. Mathieu, C.; Gysemans, C.; Giulietti, A. and Bouillon, R. (2005) Vitamin D and diabetes. Diabetologia, 48(7), 1247-1257.
88. Mitri, J.; Muraru, M.D. and Pittas, A.G. (2011) Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr., 65(9), 1005- 1015.
89. Van Etten, E. and Mathieu, C. (2005) Immunoregulation by 1,25- dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 97(1-2), 93-101.
90. Wolden-Kirk, H.; Rondas, D.; Bugliani, M.; Korf, H.; Van Lommel , L.; Brusgaard, K.; Christesen, H.T.; Schuit, F.; Proost, P.; Masini, M.; Marchetti, P.; Eizirik, D.L.; Overbergh, L. and Mathieu C. (2014) Discovery of molecular pathways mediating 1,25- dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology, 155(3), 736-747.
91. Guo, J.; Xiao, Z.; Xue, X.; Liu, X.; Lu, Y.; Yin, X. and Ma, K. (2013) 25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells. Pak. J. Med. Sci., 29(3), 809.
92. Seshadri, K.G.T and Rajendran, B. A. (2011) Role of Vitamin D on Diabetes. J. Endocrinol. Metab., 1(2), 47-56.
93. Esteghamati, A.; Aryan, Z.; Esteghamati, A. and Nakhjavani, M. (2014) Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: Associations with inflammatory and cardiometabolic markers in 4391 subjects. Diabetes Metab, 40(5), 347-355.
94. Knekt, P.; Laaksonen, M.; Mattila, C.; Harkanen, T.; Marniemi, J.; Heliovaara, M.; Rissanen, H.; Montonen, J. and Reunanen, A. (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology, 19(5), 666-671.
95. Pittas, A.G.; Dawson-Hughes, B.; Li, T.; Van Dam, R.M.; Willett, W.C.; Manson, J.E. and Hu, F.B. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care, 29(3), 650-656.
96. Liu, S.; Song, Y.; Ford, E.S.; Manson, J.E.; Buring, J.E. and Ridker, P.M. (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care, 28(12), 2926-2932.
97. Afzal, S.; Brondum-Jacobsen, P.; Bojesen, S.E. and Nordestgaard, B.G. (2014) Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol., 2(4), 298-306.
98. Song, Y.; Wang, L.; Pittas, A.G.; Del Gobbo, L.C. and Zhang, C. (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes-a meta-analysis of prospective studies. Diabetes Care, 36, 1422-1428.
99. Gagnon, C.; Lu, Z.X.; Magliano, D.J.; Dunstan, D.W. and Shaw, J.E. (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, populationbased prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care, 34, 1133-1138
100. Kayaniyil, S.; Vieth, R.; Retnakaran, R.; Knight, J.A.; Qi, Y.; Gerstein, H.C.; Perkins, B.A.; Harris, S.B.; Zinman, B. and Hanley, A.J. (2010) Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care, 33(6), 1379-1381.
101. Broder, A.R.; Tobin, J.N. and Putterman, C. Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res. Ther, 12(5), R191.
102. Bellan, M.; Guzzaloni, G.; Rinaldi, M.; Merlotti, E.; Ferrari, C.; Tagliaferri, A.; Pirisi, M.; Aimaretti, G.; Scacchi, M. and Marzullo P. (2014) Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity, Cardiovascular Diabetology, 13, 57.
103. Kostoglou-Athanassiou, I.; Athanassiou, P.; Gkountouvas, A. and Kaldrymides, P. (2013) Vitamin D and glycemic control in diabetes mellitus type 2. Ther. Adv. Endocrinol. Metab., 4(4), 122-8.
104. Stadlmayr, A.; Aigner, E.; Huber-Schonauer, U.; Niederseer, D.; Zwerina, J.; Husar-Memmer, E.; Hohla, F.; Schett, G.; Patsch, W. and Datz, C. (2014) Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol. [Epub ahead of print]
105. Pittas, A.G.; Harris, S.S.; Stark, P.C. and Dawson-Hughes, B. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care, 30(4), 980-986.
106. Shab-Bidar, S.; Neyestani, T.R.; Djazayery, A.; Eshraghian, M.R.; Houshiarrad, A.; Gharavi, A.; Kalayi, A.; Shariatzadeh, N.; Zahedirad, M.; Khalaji, N. and Haidari, H. (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med., 9, 125.
107. Ghavamzadeh, S.; Mobasseri, M. and Mahdavi R., (2014) The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients. Int. J. Prev. Med., 5(9), 1091-1098.
108. Neyestani, T.R.; Nikooyeh B.; Alavi-Majd, H.; Shariatzadeh, N.; Kalayi, A.; Tayebinejad, N.; Heravifard, S.; Salekzamani, S. and Zaedirad, M. (2012) Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab., 97(6), 2001-2011.
109. Witham, M.D.; Dove, F.J.; Dryburgh, M.; Sugden, J.A.; Morris, A.D. and Struthers A.D. (2010) The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomized controlled trial. Diabetologia, 53, 2112- 2119.
110. Ryu, O.H.; Lee, S.;Yu, J.; Choi, M.G.; Yoo, H.J. and Mantero, F. (2014) A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr. J., 61(2), 167-176.
111. Alkharfy, K.M.; Al-Daghri, N.M.; Sabico, S.B.; Al-Othman, A.; Moharram, O.; Alokail, M.S.; Al-Saleh, Y.; Kumar, S. and Chrousos, G.P. (2013) Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a oneyear prospective study. Cardiovasc. Diabetol., 12(1), 113.
112. Nilas, L. and Christiansen, C. (1984) Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int. J. Obes., 8(5), 407-411.
113. Sugden, J.A.; Davies J.I.; Witham, M.D.; Morris, A.D. and Struthers, A.D. (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet. Med., 25(3), 320-325.
114. Jorde, R. and Figenschau, Y. (2009) Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur. J. Nutr., 6, 349-354.
115. Zittermann, A.; Frisch, S.; Berthold, H.K.; Gotting, C.; Kuhn, J.; Kleesiek, K.; Stehle, P.; Koertke, H. and Koerfer, R. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr., 89(5), 1321-1327.
116. von Hurst, P.R.; Stonehouse, W. and Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br. J. Nutr., 103(4), 549-555.
117. Salehpour, A.; Shidfar, F.; Hosseinpanah, F.; Vafa, M.; Razaghi, M. and Amiri, F. (2013) Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial. Diabet. Med., 30(12), 1477-1481.
118. Breslavsky, A.; Frand, J.; Matas, Z.; Boaz, M.; Barnea, Z. and Shargorodsky M. (2013)Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin. Nutr., 32(6), 970-975.
119. Talaei, A.; Mohamadi, M. and Adgi, Z.(2013) The effect of vitamin D on insulin resistance in patients with type 2 diabetes, Diabetol. Metab. Syndr., 5(1), 8.
120. de Boer, I.H.; Tinker, L.F.; Connelly, S.; Curb, J.D.; Howard, B.V.; Kestenbaum, B.; Larson, J.C.; Manson, J.E.; Margolis, K.L.; Siscovick, D.S.; Weiss, N.S. and Women's Health Initiative Investigators. (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care, 31(4), 701-707.
121. Oh, J.; Weng, S.; Felton, S.K.; Bhandare, S.; Riek, A.; Butler, B.; Proctor, B.M.; Petty, M.; Chen, Z.; Schechtman, K.B.; Bernal- Mizrachi, L. and Bernal-Mizrachi, C. (2009) 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation, 120(8), 687-698.
122. Joergensen, M.G.; Schmedes, M.D.; Tarnow, A.L.; Parving, H.H. and Rossing, P. (2010) Vitamin D levels and Mortality in Type 2 Diabetes. Diabetes Care, 33(10), 2238-2243.
123. Griz L.; Bandeira F.; Gabbay M.A.; Dib, S.; Carvalho, E.F. (2014) Vitamin D and diabetes mellitus: an update 2013. Arq Bras. Endocrinol. Metab., 58(1), 1-8.
124. Isaia, G.; Giorgino, R.; Rini, G.B.; Bevilacqua, M.; Maugeri, D. and Adami, S. (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int., 14 (7), 577-582.
125. Gradinaru, D.; Borsa, C.; Lunesco, C.; Margina, D.; Prda, D.I. and Jansen, E. (2012) Vitamin D status and oxidative stress markers in the elderly with impaired fastin glucose and type 2 diabetes mellitus. Aging Clin. Exp. Res., 24(6), 595-602.
126. Hirani, V.; Cumming, R.G.; Le Couteur, D.G.; Naganathan, M.; Blyth, F.; Handelsman, D.J.; Waite, L.M. and Seibel, M.J. (2014) Low Levels of 25-Hydroxy Vitamin D and Active 1,25-Dihydroxyvitamin D Independently Associated with Type 2 Diabetes Mellitus in Older Australian Men: The Concord Health and Ageing in Men Project. J. Am. Geriatr. Soc., 62(9), 1747-1747.
127. Bruyère, O.; Cavalier, E.; Souberbielle, J-C.; Bischoff-Ferrari, H.; Beaudart, C.; Buckinx, F.; Reginster, J.Y. and Rizzoli, R. (2014) Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health., 72(1), 3.
128. Colombo ML. (2010) An Update on Vitamin E, Tocopherol and Tocotrienol - Perspectives. Molecules, 15, 2103-2113.
129. Kataja- Tuomola, M.K., Kontto, J.P., Mannisto, S., Albanes, D. and Virtamo, J. (2011) Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur. J. Clin. Nutr., 65(5), 590-597.
130. Peerapatdit, T.; Patchanans, N.; Likidlilid, A.; Poldee, S. and Sriratanasathavorn, C. (2006) Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients. J. Med. Assoc. Thai, 89 Suppl 5, S147-S155.
131. Illison, V.K.; Rondo, P.H.; de Oliveira, A.M.; D'Abronzo, F.H. and Campos, K.F. (2011) The relationship between plasma alphatocopherol concentration and vitamin E intake in patients with type 2 diabetes mellitus. Int. J. Vitam. Nutr. Res., 81(1), 12-20.
132. Espe, K.M.; Raila, J.; Henze, A.; Blouin, K.; Schneider, A.; Schmiedeke, D.; Krane, V.; Pilz, S.; Schweigert, F.J.; Hocher, B.; Wanner, C.; Drechsler. C. and German Diabetes and Dialysis Study Investigators. (2013) Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients. Clin. J. Am. Soc. Nephrol., 8(3), 452-458.
133. Blum, S.; Vardi, M.; Brown, J.B.; Russell, A.; Milman, U.; Shapira, C.; Levy, N.S.; Miller-Lotan, R.; Asleh, R. and Levy, A.P. (2010) Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics, 11(5), 675-684.
134. Farbstein, D.; Blum, S.; Pollak, M.; Asaf, R.; Viener, H.L.; Lache, O.; Asleh, R.; Miller-Lotan, R.; Barkay, I.; Star, M.; Schwartz, A.; Kalet-Littman, S.; Ozeri, D.; Vaya, J.; Tavori, H.; Vardi, M.; Laor, A.; Bucher, S.E.; Anbinder, Y.; Moskovich, D.; Abbas, N.; Perry, N.; Levy, Y. and Levy, A.P. (2011) Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype. Atherosclerosis, 219(1), 240-244.
135. Goldenstein, H.; Levy, N.S.; Lipener, Y.T. and Levy, A.P. (2013) Patient selection and vitamin E treatment in diabetes mellitus. Expert Rev. Cardiovasc. Ther., 11(3), 319-326.
136. Vardi, M.; Blum, S. and Levy, A.P. (2012) Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur. J. Intern. Med., 23(7), 628-632.
137. de Oliveira, A.M.; Rondo, P.H.; Luzia, L.A.; D'Abronzo, F.H. and Illison, V.K. (2011) The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, doubleblind, placebo-controlled trial. Diabetes Res. Clin. Pract., 92(2), 253-260.
138. Suksomboon, N.; Poolsup, N. and Sinprasert, S. (2011) Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials. J. Clin. Pharm. Ther., 36(1), 53-63.
139. Maier, H.M.; Ilich, J,Z.; Kim, J.S. and Spicer, M.T. (2013) Nutrition supplementation for diabetic wound healing: a systematic review of current literature. Skinmed, 11(4), 217-224.
140. Shearer, M.J.; Fu, X. and Booth, S.L. (2012) Vitamin K Nutrition, Metabolism and Requierements: Current Concepts and Future Research. Adv. Nutr., 3, 182-195.
141. Juanola-Falgarona, M.; Salas-Salvadó, J.; Estruch. R.; Portillo, M.P.; Casas, R.; Miranda, J.; Martinez-Gonzalez, M.A. and Bullo, M. (2013) Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc. Diabetol., 12, 7.
142. Ibarrola-Jurado, N.; Salas-Salvado, J.; Martinez-Gonzalez, M.A. and Bullo, M. (2012) Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am. J. Clin. Nutr., 96(5), 1113-1118.
143. Beulens, J.W.; van der A, D.L.; Grobbee, D.E.; Sluijs, I.; Spijkerman, A.M. and van der Schouw, Y.T. (2010) Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care, 33(8), 1699-1705.
144. Rees, K.; Guraewal, S.; Wong, Y.L.; Majanbu, D.L.; Mavrodaris, A.; Stranges, S.; Kandala, N.B.; Clarke, A. and Franco, O.H. (2010) Is vitamin K consumption associated with cardio-metabolic disorders? A systematic review. Maturitas, 67(2), 121-128.
145. Comerford, K.B. (2013) Recent developments in multivitamin/ mineral research. Adv. Nutr, 4(6), 644-656.
146. Gariballa, S.; Afandi, B.; Abu Haltem, M.; Yassin, J. and Alessa, A. (2013) Effect of antioxidants and B-group vitamins on risk of infections in patients with type 2 diabetes mellitus. Nutrients, 5(3), 711-724.
147. Gunasekara, P.; Hettiarachchi, M.; Liyanage, C. and Lekamwasam, S. (2011) Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes. Metab. Syndr. Obes., 4, 53-60.
148. Block, G.; Jensen, C.D.; Norkus, E.P.; Dalvi, T.B.; Wong, L.G.; McManus, J.F. and Hudes, M.L. (2007) Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr. J., 6, 30.
149. Church, T.S.; Earnest, C.P.; Wood, K.A. and Kampert, J.B. (2003) Reduction of C-reactive protein levels through use of a multivitamin. Am. J. Med., 115(9), 702-707.
150. Song, Y.; Xu, Q.; Park, Y.; Hollenbeck, A.; Schatzkin, A. and Chen, H. (2011) Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care, 1, 108-114.
151. Barringer, T.A.; Kirk, J.K.; Santaniello, A.C.; Foley, K.L. and Michielutte, R. (2003) Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, doubleblind, placebo-controlled trial. Ann. Intern. Med., 138(5), 365-371.
152. Martini, L.A.; Catania, A.S. and Ferreira, S.R. (2010) Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr. Rev., 68(6), 341-54.
153. Cuerda, C.; Luengo, L.M.; Valero, M.A.; Vidal, A.; Burgos, R.; Calvo, F.L. and Martinez, C. (2011) Antioxidants and diabetes mellitus: review of the evidence. Nutr. Hosp., 26(1), 68-78.